GLP‐1 receptor agonists in patients with MGUS: A real‐world propensity‐matched study
GLP-1 RA therapy was associated with significantly improved PFS and OS in MGUS patients with metabolic comorbidities. While fewer cardiovascular events were observed, these findings were not statistically confirmed over time.
Authors
- Efstathios Kastritis (ORCID: https://orcid.org/0000-0001-8191-5832)
- Ioannis Ntanasis‐Stathopoulos (ORCID: https://orcid.org/0000-0002-6328-9783)
- Anastasios Tentolouris (ORCID: https://orcid.org/0000-0001-5897-472X)
- Meletios Α. Dimopoulos (ORCID: https://orcid.org/0000-0001-8990-3254)
- Evangelos Terpos (ORCID: https://orcid.org/0000-0001-5133-1422)
- Ernesto Ruiz Duque (ORCID: https://orcid.org/0000-0002-9777-4883)
- Charalampos Filippatos (ORCID: https://orcid.org/0009-0005-8971-269X)
- Αlexandros Briasoulis (ORCID: https://orcid.org/0000-0002-5740-9670)
- Maria Gavriatopoulou (ORCID: https://orcid.org/0000-0002-6244-1229)
Institutions
- University of Iowa (US)
- Korea University (KR)
- National and Kapodistrian University of Athens (GR)
- Alexandra Hospital (GR)
- Laiko General Hospital of Athens (GR)
- Korea University (JP)
Publication Details
- Journal
- European Journal of Clinical Investigation
- Published
- 2025-10-22
- DOI
- https://doi.org/10.1111/eci.70140
- Citations
- 2
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 2.59